 <h1>Mayzent Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>siponimod</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about siponimod. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Mayzent.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to siponimod: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, siponimod (the active ingredient contained in Mayzent) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking siponimod:</p><p>
<i>More common</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blurred vision</li>
<li>chest pain or discomfort</li>
<li>fast, slow, or irregular heartbeat</li>
<li>headache</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>rapid weight gain</li>
<li>tingling of the hands or feet</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>change in vision</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>difficulty in speaking</li>
<li>double vision</li>
<li>fever</li>
<li>hoarseness</li>
<li>inability to move the arms, legs, or facial muscles</li>
<li>inability to speak</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>numbness or tingling in the face, arms or legs</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>painful blisters on the trunk of the body</li>
<li>painful or difficult urination</li>
<li>pounding, slow heartbeat</li>
<li>seizures</li>
<li>slow speech</li>
<li>sweating</li>
<li>tremor</li>
<li>trouble speaking, thinking, or walking</li>
<li>trouble breathing</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Change in the size, shape, or color of existing mole</li>
<li>mole that leaks fluid or bleeds</li>
<li>new mole</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of siponimod may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Arm or leg pain</li>
<li>diarrhea</li>
<li>falls</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Lack or loss of strength</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to siponimod: oral tablet</i></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphopenia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infections (e.g., herpes zoster, bronchitis, sinusitis, upper respiratory infection, fungal skin infection) (49%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Macular edema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Edema peripheral (e.g., edema peripheral, joint swelling, fluid retention, swelling face)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevations in transaminases (e.g., alanine aminotransferase increased, gamma-glutamyltransferase increased, hepatic enzyme increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, liver function test increased, hepatic function abnormal, liver function test abnormal, transaminases increased) (10%), increased bilirubin (10%)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Malignancy (e.g., melanoma in situ, seminoma)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Bronchitis, sinusitis, upper respiratory infection</p>
<p><b>Common</b> (1% to 10%): Pulmonary embolism, pulmonary function test decreased<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Falls (11%)</p>
<p><b>Common</b> (1% to 10%): Macular edema, asthenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (e.g., headache, tension headache, sinus headache, cervicogenic headache, drug withdrawal headache, procedural headache) (15%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, seizure, tremor</p>
<p><b>Frequency not reported</b>: Posterior reversible encephalopathy syndrome (PRES)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (e.g., blood pressure increased, blood pressure systolic increased, essential hypertension, blood pressure diastolic increased) (13%)</p>
<p><b>Common</b> (1% to 10%): First-degree AV block, second-degree AV block (usually Mobitz type I), bradycardia, ischemic stroke, myocardial infarction<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Fungal skin infection<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Mayzent (siponimod)." Novartis Pharmaceuticals, East Hanover, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How much does Mayzent cost?</li>
<li>Vumerity vs Mayzent - what's the difference?</li>
<li>How does Mayzent work?</li>
<li>How long do you take Mayzent for?</li>
<li>Can people with end stage renal disease take Mayzent?</li>
<li>What are the new drugs used for multiple sclerosis (MS)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Mayzent (siponimod)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>2 Reviews</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mayzent &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to siponimod: oral tablet</i></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphopenia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infections (e.g., herpes zoster, bronchitis, sinusitis, upper respiratory infection, fungal skin infection) (49%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Macular edema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Edema peripheral (e.g., edema peripheral, joint swelling, fluid retention, swelling face)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevations in transaminases (e.g., alanine aminotransferase increased, gamma-glutamyltransferase increased, hepatic enzyme increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, liver function test increased, hepatic function abnormal, liver function test abnormal, transaminases increased) (10%), increased bilirubin (10%)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Malignancy (e.g., melanoma in situ, seminoma)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Bronchitis, sinusitis, upper respiratory infection</p><p><b>Common</b> (1% to 10%): Pulmonary embolism, pulmonary function test decreased<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Falls (11%)</p><p><b>Common</b> (1% to 10%): Macular edema, asthenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (e.g., headache, tension headache, sinus headache, cervicogenic headache, drug withdrawal headache, procedural headache) (15%)</p><p><b>Common</b> (1% to 10%): Dizziness, seizure, tremor</p><p><b>Frequency not reported</b>: Posterior reversible encephalopathy syndrome (PRES)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (e.g., blood pressure increased, blood pressure systolic increased, essential hypertension, blood pressure diastolic increased) (13%)</p><p><b>Common</b> (1% to 10%): First-degree AV block, second-degree AV block (usually Mobitz type I), bradycardia, ischemic stroke, myocardial infarction<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Fungal skin infection<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Mayzent (siponimod)." Novartis Pharmaceuticals, East Hanover, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How much does Mayzent cost?</li>
<li>Vumerity vs Mayzent - what's the difference?</li>
<li>How does Mayzent work?</li>
<li>How long do you take Mayzent for?</li>
<li>Can people with end stage renal disease take Mayzent?</li>
<li>What are the new drugs used for multiple sclerosis (MS)?</li>
</ul><h2>More about Mayzent (siponimod)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>2 Reviews</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mayzent &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>